AI could make colonoscopies easier for lynch syndrome patients

NCT ID NCT05963191

Recruiting now Disease control Sponsor: PERROD Guillaume Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether an artificial intelligence system called CAD-EYE can detect precancerous polyps during colonoscopy in people with Lynch syndrome, a genetic condition that raises colon cancer risk. The AI is compared to the current best method, dye-spray chromoendoscopy, which is effective but time-consuming. If CAD-EYE works as well, it could simplify screening for these high-risk patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CAD-EYE system (artificial intelligence device for polyp detection during colonoscopy)
What this could lead to: If successful, this could offer a faster, easier screening method for Lynch syndrome patients that is as effective as the current standard dye-spray technique.
What could go wrong: This is a non-inferiority trial, so the AI may prove no better than standard care. The study is still recruiting and results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYNCH SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Colorectal Neoplasms, Hereditary Nonpolyposis Lynch syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYNCH SYNDROME

Contacts and locations

Locations

Hôpital Européen Georges-Pompidou HEGP
RECRUITING

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.